 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Micol Rothman and Sean Iwamoto.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.628 |
|
|
|
-
Rothman MS, Hamnvik OR, Davidge-Pitts C, Safer JD, Ariel D, Tangpricha V, Abramowitz J, Soe K, Sarvaideo J, Kelley C, Irwig MS, Iwamoto SJ. Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgend Health. 2024 Dec; 9(6):463-465.
Score: 0.964
-
Rothman MS, Ariel D, Kelley C, Hamnvik OR, Abramowitz J, Irwig MS, Soe K, Davidge-Pitts C, Misakian AL, Safer JD, Iwamoto SJ. The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels. Endocr Pract. 2024 Sep; 30(9):870-878.
Score: 0.926
-
Iwamoto SJ, Rice JD, Moreau KL, Cornier MA, Wierman ME, Mancuso MP, Gebregzabheir A, Hammond DB, Rothman MS. The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults. J Clin Transl Endocrinol. 2024 Jun; 36:100348.
Score: 0.923
-
Iwamoto SJ, Defreyne J, Kaoutzanis C, Davies RD, Moreau KL, Rothman MS. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults. Ther Adv Endocrinol Metab. 2023; 14:20420188231166494.
Score: 0.859
-
Iwamoto SJ, Grimstad F, Irwig MS, Rothman MS. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. J Gen Intern Med. 2021 05; 36(5):1380-1389.
Score: 0.738
-
Iwamoto SJ, T'Sjoen G, Safer JD, Davidge-Pitts CJ, Wierman ME, Glodowski MB, Rothman MS. Letter to the Editor: "Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen". J Clin Endocrinol Metab. 2019 08 01; 104(8):3127-3128.
Score: 0.664
-
Rothman MS, Iwamoto SJ. Bone Health in the Transgender Population. Clin Rev Bone Miner Metab. 2019 Jun; 17(2):77-85.
Score: 0.660
-
Iwamoto SJ, Rothman MS, T'Sjoen G, Defreyne J. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):592-602.
Score: 0.226
-
Hoffner-Heinike A, Iwamoto SJ, Saxon DR, Cogdall NA, Davies RD, Lee RS, Chiappone A, Thomas JF, Rothman MS. ECHO "Bootcamp": An Innovative Training Model to Onboard Providers in the Care of Gender Diverse Patients. Telemed J E Health. 2024 Feb; 30(2):430-437.
Score: 0.219
-
Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. 2020 04; 133:115224.
Score: 0.171
-
Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, T'Sjoen G. Health considerations for transgender women and remaining unknowns: a narrative review. Ther Adv Endocrinol Metab. 2019; 10:2042018819871166.
Score: 0.167
-
Misakian AL, Kelley CE, Sullivan EA, Chang JJ, Singh G, Kokosa S, Avila J, Cooper H, Liang JW, Botzheim B, Quint M, Jeevananthan A, Chi E, Harmer M, Hiatt L, Kowalewski M, Steinberg B, Tausinga T, Tanner H, Ho TF, Mark B, Zenger B, Hu S, Gebregzabheir A, Penny JM, Loeb DF, Strickland T, Iwamoto SJ, Rothman MS, Hamnvik OR, Ariel D. Injectable Estradiol Use in Transgender and Gender-Diverse Individuals in the U.S.: A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2025 Jan 11.
Score: 0.061
-
Sotiros AR, Iwamoto SJ, Rothman MS, Lee RS. A Novel Multidisciplinary Model of Care for Transgender and Gender Diverse Adults: Program Description and Patient Perspectives. Transgend Health. 2022 Jun; 7(3):276-281.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|